Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
interferon alfa-n3 (Alferon-N) (1 trial)
Coronavirus Infections (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)